4.7 Article

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study

Hyeontaek Hwang et al.

Summary: This study investigated the efficacy and safety of Pirfenidone in real-world patients with IPF. The results showed that Pirfenidone continued to slow the progression of IPF even with a consistently lower dose. The study also demonstrated that Pirfenidone treatment significantly reduced the decline rate of FVC, and adverse events and mortality were not dose-dependent.

KOREAN JOURNAL OF INTERNAL MEDICINE (2022)

Review Respiratory System

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Toby M. Maher et al.

RESPIRATORY RESEARCH (2019)

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Respiratory System

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

Lisa H. Lancaster et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Article Respiratory System

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results

Goran Nadir Salih et al.

EUROPEAN CLINICAL RESPIRATORY JOURNAL (2016)

Review Medicine, Research & Experimental

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

Ulrich Costabel et al.

ADVANCES IN THERAPY (2014)

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

Brett Ley et al.

ANNALS OF INTERNAL MEDICINE (2012)

Review Critical Care Medicine

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

Brett Ley et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Respiratory System

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Review Respiratory System

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

N MacIntyre et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Respiratory System

Standardisation of spirometry

MR Miller et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Critical Care Medicine

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

A Azuma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)